Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer
Breast Cancer Rates Decline Most for Affluent White Women
Low Prevalence Of Tamoxifen Use For Cancer Prevention
Symptoms Don’t Help Detect Early-Stage Ovarian Cancer
Two-Week Break Balances RT Palliation, Side Effects
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
